| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/01/2005 | WO2005080592A1 Method of immobilizing nucleic acid aptamers |
| 09/01/2005 | WO2005080591A1 Assay for gata4 mutation indicated in a medical condition |
| 09/01/2005 | WO2005080590A1 Method for detecting prp using a molecule containing at least one positive charge and/or at least one osidic bond and a ligand other than a proteinic ligand |
| 09/01/2005 | WO2005080589A1 Diagnostics and therapeutics for diseases associated with kallikrein 3 (klk3) |
| 09/01/2005 | WO2005080588A2 2031 oxidoreductase |
| 09/01/2005 | WO2005080587A2 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation |
| 09/01/2005 | WO2005080575A1 Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles |
| 09/01/2005 | WO2005080574A1 Transgenic mouse model and method for evaluating glucocerebrosidase deficiencies |
| 09/01/2005 | WO2005080570A1 Gene relating to estimation of postoperative prognosis for breast cancer |
| 09/01/2005 | WO2005080566A1 Isolating, positioning, and sequencing single molecules |
| 09/01/2005 | WO2005080565A1 Dna array for analyzing dna methylation, method of constructing the same and mehtod of analyzing dna methylaion |
| 09/01/2005 | WO2005080563A1 Method of detecting bifidobacterium infantis |
| 09/01/2005 | WO2005080562A1 Method of adjudicating on prostate cancer |
| 09/01/2005 | WO2005080550A1 Lactic acid with high nisin-productivity and method of selecting the same |
| 09/01/2005 | WO2005080420A2 Hyphal growth in fungi |
| 09/01/2005 | WO2005080410A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders |
| 09/01/2005 | WO2005079986A1 Multi-step bioassays on modular microfluidic application platforms |
| 09/01/2005 | WO2005079830A1 Inhibitors of amyloid fibril formation and uses thereof |
| 09/01/2005 | WO2005079822A2 Pharmaceutical composition comprising a fibrin matrix and dermal fibroblasts for the treatment of wounds |
| 09/01/2005 | WO2005079821A1 Wound healing profile |
| 09/01/2005 | WO2005079532A2 Methods and compositions for enhancing risc activity in vitro and in vivo |
| 09/01/2005 | WO2005079523A2 Novel teleost derived antimicrobal polypeptides |
| 09/01/2005 | WO2005079474A2 Detection of nucleic acid sequence differences by comparative genomic hybridization |
| 09/01/2005 | WO2005079462A2 Methods and materials using signaling probes |
| 09/01/2005 | WO2005079458A2 ENHANCEMENT OF Th2-DEPENDENT AND INFLAMMATORY RESPONSE |
| 09/01/2005 | WO2005079380A2 Identification of soybeans having resistance to phytophthora sojae |
| 09/01/2005 | WO2005079367A2 Schizochytrium fatty acid synthase (fas) and products and methods related thereto |
| 09/01/2005 | WO2005079357A2 Nucleic acid representations utilizing type iib restriction endonuclease cleavage products |
| 09/01/2005 | WO2005079342A2 Methods for coupling resistance alleles in tomato |
| 09/01/2005 | WO2005079331A2 Methods and compositions for inferring eye color and hair color |
| 09/01/2005 | WO2005079325A2 Genetic predictability for acquiring a disease or condition |
| 09/01/2005 | WO2005079316A2 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof |
| 09/01/2005 | WO2005079300A2 Protein kinase inhibitors and methods for identifying same |
| 09/01/2005 | WO2005079277A2 High throughput screening methods for lubricating oil compositions |
| 09/01/2005 | WO2005079276A2 Selective growth medium for listeria spp |
| 09/01/2005 | WO2005079196A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in prokaryotes |
| 09/01/2005 | WO2005079181A2 Dry and semidry enrichment for the detection of foodborne pathogens |
| 09/01/2005 | WO2005079173A2 A plynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide |
| 09/01/2005 | WO2005079153A2 Solid-fluid composition and uses thereof |
| 09/01/2005 | WO2005061734A3 Double stranded linear nucleic acid probe and uses thereof |
| 09/01/2005 | WO2005054283A3 Clp-protease as target for herbicides |
| 09/01/2005 | WO2005052191A8 Compositions and methods for the diagnosis and treatment of tumor |
| 09/01/2005 | WO2005047476A3 Inhibition of retroviral replication through modulation of the host cell ubiquitylation |
| 09/01/2005 | WO2005042786A3 Compositions and methods for glioma classification |
| 09/01/2005 | WO2005040402A3 Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2 (naaladase 2) |
| 09/01/2005 | WO2005033314A3 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 09/01/2005 | WO2005032347A3 Determining the chemosensitivity of cells to cytotoxic agents |
| 09/01/2005 | WO2005031001A3 Novel therapeutic targets in cancer |
| 09/01/2005 | WO2005029705A3 Number coding for identification of subtypes of coded types of solid phase carriers |
| 09/01/2005 | WO2005028674A3 Methods and kits useful for detecting an alteration in a locus copy number |
| 09/01/2005 | WO2005028109B1 Microplates useful for conducting thermocycled nucleotide amplification |
| 09/01/2005 | WO2005024426A3 HIGH-THROUGHPUT-ASSAY WITH HIGH SENSITIVITY FOR MEASURING OF THE ACTIVITY OF β-ADRENERGIC RECEPTOR KINASE AND FOR DETERMINING THE IMPACT OF TEST SUBSTANCES ON SUCH ACTIVITY |
| 09/01/2005 | WO2005024029A3 Plants having modified growth characteristics and method for making the same |
| 09/01/2005 | WO2005017113B1 Metalloproteinase gene polymorphism in copd |
| 09/01/2005 | WO2004106557A3 Thiamin production by fermentation |
| 09/01/2005 | WO2004101809A3 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| 09/01/2005 | WO2004078992A3 Methods for the identification of inhibitors of pyrroline-5-carboxylate reductase as antibiotics |
| 09/01/2005 | WO2004076639A8 Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus |
| 09/01/2005 | WO2004062475A3 Fluorescent assays for protein kinases |
| 09/01/2005 | WO2004042019A3 Systems for capture and analysis of biological particles and methods using the systems |
| 09/01/2005 | WO2004024076A8 Novel compositions and methods for the treatment of immune related diseases |
| 09/01/2005 | WO2004009540A8 Methods and kits for transferases |
| 09/01/2005 | WO2003104399A3 Cancer-linked gene as target for chemotherapy |
| 09/01/2005 | WO2003091417A3 Self-similar ordered microstructural arrays of amphiphilic molecules |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050193443 Using vector transformation to generate transgenic plants with enhanced resistance to drought and high environments |
| 09/01/2005 | US20050193434 IL-21 as a regulator of immunoglobin production |
| 09/01/2005 | US20050192763 Method of selecting optimized SNP marker sets from multiple SNP markers associated with a complex disease |
| 09/01/2005 | US20050192438 to replace the fragile proteinaceous ion pores currently used for studying DNA translocation; 1,4-bis(4-ethynylpyridine)benzene complexed with bis(trioctylphosphino)-platinum(II)bis(trifluoromethanesulphonate) |
| 09/01/2005 | US20050192327 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 09/01/2005 | US20050192326 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/01/2005 | US20050192312 Naphthalimide dosing by N-acetyl transferase genotyping |
| 09/01/2005 | US20050192239 Methods for identifying risk of breast cancer and treatments thereof |
| 09/01/2005 | US20050191761 Analyte sensing via acridine-based boronate biosensors |
| 09/01/2005 | US20050191751 Apparatus which utilizes presence of intrinsic tenase-dependent fibrin as tool in diagnosing individuals as hypercoagulable, normal and/or hypocoagulable; blood disorders |
| 09/01/2005 | US20050191739 Polyphenol oxidase genes from banana, lettuce, tobacco and pineapple |
| 09/01/2005 | US20050191732 Vector comprising nucleotide sequences coding homeostasis and adaptation (HA) proteins for use in enhancing/improving heterologous gene expression |
| 09/01/2005 | US20050191723 Improving gene expression in host cells vial use of vector comprising stabilizing anti-repressor (STAR) sequences; enhancer elements |
| 09/01/2005 | US20050191719 Using adenosine triphosphatase as tool for detecting modulators of immune response |
| 09/01/2005 | US20050191718 Methods for measuring phosphatase activity |
| 09/01/2005 | US20050191717 Adding a reagent to a glucose polymer that is capable of reacting with a peptidoglycan; determining the amount of peptidoglycan; and, if it is determined that a sufficiently low level of the peptidoglycan is present, using it to make the dialysis solution |
| 09/01/2005 | US20050191713 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof |
| 09/01/2005 | US20050191710 Method for labeling a membrane-localized protein |
| 09/01/2005 | US20050191703 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides |
| 09/01/2005 | US20050191699 Reactive probe chip, composite substrate and method for fabrication of the same |
| 09/01/2005 | US20050191698 Determining gene sequences using pyrophosphate generated DNA synthesis reaction (pyrosequencing) |
| 09/01/2005 | US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 09/01/2005 | US20050191695 Documentation means for repertoires of NKR immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of NKR immunoreceptors |
| 09/01/2005 | US20050191694 Apparatus comprising microarray for parallel screening of analytes found in agricultural, forensic, veterinary and blood samples |
| 09/01/2005 | US20050191693 Bioassay comprising stem cell population for use as models in genomic targeting and drug screening |
| 09/01/2005 | US20050191691 Gene sequence variances in genes related to folate metabolism having utility in determining the treatment of disease |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191687 Method for multiplexed analyte detection |
| 09/01/2005 | US20050191686 Micro PCR device, method for amplifying nucleic acids using the micro PCR device, and method for measuring concentration of PCR products using the micro PCR device |
| 09/01/2005 | US20050191685 Method for determining the risk of developing a neurological disease |
| 09/01/2005 | US20050191684 Transgenic gramnegative bacteria comprising enhanced 6-phosphogluconolactonase activity for fermentation of tryptophan, phenylalanine and tyrosine for use in cosmetics, medicine and animal feeds |
| 09/01/2005 | US20050191683 Biomolecule sensing method using Field Effect Transistor with controllable Debye length |
| 09/01/2005 | US20050191682 Via exposure to acidic conditions to generate abasic positions and then cleavage of abasic sites by apurinic/apyrimidinic endonuclease |
| 09/01/2005 | US20050191680 Therapeutic nucleic acid-3' -conjugates |
| 09/01/2005 | US20050191679 Schizochytrium fatty acid synthase (FAS) and products and methods related thereto |